1Department of Pharmacy, Flinders Medical Centre, Bedford Park, SA, Australia
2School of Medicine, Flinders University, Adelaide, SA, Australia
3School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, SA, Australia
4Flinders Centre for Innovation in Cancer, Flinders University, Adelaide, SA, Australia
5Flinders Centre for Epidemiology and Biostatistics, School of Medicine, Flinders University, Adelaide, Australia
6SA Pathology, Microbiology and Infectious Diseases, Flinders Medical Centre, Bedford Park, SA, Australia
7Division of Medicine, Flinders Medical Centre, Bedford Park, SA, Australia
© 2017, Korea Health Personnel Licensing Examination Institute
This is an open-access article distributed under the terms of the Creative Commons Attribution License <http://creativecommons.org/licenses/by/4.0/>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Authors’ contributions
Conceptualization: CJP, DLG, RAM. Data Curation: CJP. Formal analysis: RJW. Funding acquisition: CJP. Methodology: CJP, DLG, RAM, RJW. Writing—original draft: CJP. Writing—review & editing: DLG, RAM, RJW
Conflict of interest
The authors declare they have no potential conflict of interest
Funding
This work was supported by a National Health and Medical Research Council of Australia (FundRef ID 501100000925) Translating Research into Practice Fellowship (1035960) awarded to CJP.
Junior doctors' characteristics | Early in training year (n = 120) | Late in training year (n = 75) | P-valuea) |
---|---|---|---|
Hospital position | 0.83 | ||
PGY1 | 115 (95.8) | 73 (97.3) | |
PGY2 | 3 (2.5) | 2 (2.7) | |
Other | 2 (1.7) | 0 | |
How many times prescribed vancor ycin | <0.001 | ||
≤10 times | 108 (90.0) | 49 (65.3) | |
11-20 times | 9 (7.5) | 16 (21.3) | |
21-30 times | 1 (0.8) | 7 (9.3) | |
>30 times | 0 | 3 (4.0) | |
Missing | 2 (1.7) | - |
Confidence domains “do you feel confident to” | Early in training year (n = 120) | Late in training year (n = 75) | P-valuea) |
---|---|---|---|
Treat patients with VAN? | 3.2±0.98 (3.1-3.4) | 2.3±0.76 (2.1-2.5) | < 0.001 |
Choose an initial VAN dose? | 3.1 ±0.99 (2.9-3.3) | 1.9±0.67 (1.8-2.1) | < 0.001 |
Choose a maintenance VAN dose | 3.1 ±0.88 (3.0-3.3) | 2.0±0.74 (1.9-2.2) | < 0.001 |
Know when the first blood level of VAN should be measured? | 3.2 ±0.90 (3.0-3.3) | 2.1 ±0.70 (2.0-2.3) | < 0.001 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 3.3±0.87 (3.1-3.4) | 2.26±0.73 (2.1-2.4) | < 0.001 |
Know the target therapeutic range for VAN? | 3.1 ±1.1 (2.9-3.3) | 2.1 ±0.81 (1.9-2.3) | < 0.001 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 3.2±0.94 (3.0-3.3) | 2.2±0.91 (2.0-2.4) | < 0.001 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.8±0.98 (3.6-4.0) | 3.2±1.1 (2.9-3.4) | < 0.001 |
Confidence domains “do you feel confident to” | Did not attend prior educational session (n = 25) | Attended prior educational session (n = 49) | P-valuea) |
---|---|---|---|
Treat patients with VAN? | 2.5±0.9 (2.1-2.9) | 2.2±0.7 (2.0-2.4) | 0.09 |
Choose an initial VAN dose? | 2.0±0.6 (1.7-2.3) | 1.9±0.7 (1.7-2.1) | 0.47 |
Choose a maintenance VAN dose | 2.2±0.9 (1.8-2.6) | 1.9±0.7 (1.7-2.1) | 0.15 |
Know when the first blood level of VAN should be measured? | 1.9±0.6 (1.8-2.1) | 2.4±0.8 (2.1-2.8) | <0.05 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 2.5±0.9 (2.2-2.9) | 2.1±0.6 (2.0-2.3) | 0.02 |
Know the target therapeutic range for VAN? | 2.0±0.7 (1.8-2.2) | 2.3±0.9 (1.9-2.7) | 0.13 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 2.5±1.1 (2.1-2.9) | 2.1±0.8 (1.8-2.3) | 0.05 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.4±1.3 (2.8-3.9) | 3.1±1.0 (2.8-3.4) | 0.28 |
Confidence domains regarding vancomycin “do you feel confident to” | JMO without pocket guidelines (n = 17) | JMO with pocket guidelines (n = 58) | P-valuea) |
---|---|---|---|
Treat patients with VAN? | 2.9±0.9 (2.4-3.3) | 2.1±0.6 (1.9-2.2) | < 0.001 |
Choose an initial VAN dose? | 2.3±0.7 (1.9-2.6) | 1.8±0.6 (1.6-2.0) | 0.01 |
Choose a maintenance VAN dose | 2.6±0.8 (2.2-2.9) | 1.9±0.7 (1.7-2.1) | < 0.001 |
Know when the first blood level of VAN should be measured? | 2.4±0.8 (2.0-2.8) | 2.0±0.6 (1.9-2.2) | 0.06 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 2.6±0.7 (2.1-3.0) | 2.2±0.7 (2.0-2.3) | 0.03 |
Know the target therapeutic range for VAN? | 2.3±0.8 (2.0-2.7) | 2.0±0.8 (1.8-2.2) | 0.13 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 2.7±1.1 (2.1-3.3) | 2.1±0.8 (1.8-2.3) | 0.01 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.0±1.1 (2.7-3.2) | 3.8±1.2 (3.2-4.4) | < 0.01 |
Knowledge questions on VAN from clinical vignettes | All | Prescribed VAN ≤10 times (n = 57) | Prescribed VAN >10 times (n = 26) | P-valuea) | Did not attend prior educational session (n = 40) | Attended prior educational session (n = 45) | P-valuea) | No pocket guidelines (n = 27) | Possession of pocket guidelines (n = 58) | P-valuea) |
---|---|---|---|---|---|---|---|---|---|---|
What loading dose would you prescribe? | 75 (88.2) | 55 (93) | 20(77) | 0.06 | 37 (92.5) | 38 (84.4) | 32 | 22 (81.5) | 53(91.4) | 0.28 |
What subsequent maintenance dose would you prescribe? | 77 (89.4) | 51 (86) | 25 (96) | 0.26 | 38 (95.0) | 38 (84.4) | 0.16 | 24 (88.9) | 52 (89.7) | 1.00 |
Before which dose should you take the first VAN level? | 81 (953) | 55 (93) | 26(100) | 31 | 39 (97.5) | 42 (93.3) | 0.62 | 26 (96.3) | 55 (94.8) | 1.00 |
If the patient had a creatinine clearance of 30 mlVmin, before which dose would you take the first VAN level? | 77 (89.4) | 51 (86) | 23 (88) | 1 | 32 (80.0) | 42 (93.3) | 0.1 | 21 (77.8) | 53 (91.4) | 0.10 |
What is the therapeutic range (intermittent infusion) for vancomycin recommended by the pathology laboratory? | 81 (953) | 55 (93) | 26(100) | 31 | 38 (95.0) | 43 (95.6) | 1 | 26 (963) | 55 (94.8) | 1.00 |
A patient's initial VAN levels returns as 23.2 mg/L; what dosing regimen will you prescribe? | 70 (82.4) | 47 (80.0) | 23 (88.5) | 0.54 | 36 (90.0) | 34 (75.6) | 0.1 | 20 (74.0) | 50 (86.2) | 0.15 |
When should the patient's next VAN trough level be checked? | 77 (89.4) | 53 (89.8) | 24 (92.3) | 1 | 37 (92.5) | 40 (88.9) | 0.72 | 24 (88.9) | 53(91.4) | 0.71 |
How often should a VAN level be measured once the patient is in the target range (provided stable renal function)? | 79 (92.9) | 54(91.5) | 25(96.1) | 0.66 | 38 (95.0) | 41 (91.1) | 0.68 | 26 (96.3) | 53 (91.4) | 0.66 |
If a patient develops red man syndrome, what changes will you make to the VAN infusion rate? | 51 (60) | 36 (61.0) | 14(53.8) | 0.63 | 25 (62.5) | 25 (55.6) | 0.66 | 14(51.9) | 36 (62.1) | 0.48 |
How many consecutive VAN levels within the target range will the patient require prior to discharge home for outpatient antimicrobial therapy with VAN? | 65 (76.5) | 46 (78.0) | 18(69.2) | 0.42 | 30 (75.0) | 34 (75.6) | 1 | 20 (74.0) | 44 (75.9) | 1.00 |
Junior doctors' characteristics | Early in training year (n = 120) | Late in training year (n = 75) | P-value |
---|---|---|---|
Hospital position | 0.83 | ||
PGY1 | 115 (95.8) | 73 (97.3) | |
PGY2 | 3 (2.5) | 2 (2.7) | |
Other | 2 (1.7) | 0 | |
How many times prescribed vancor ycin | <0.001 | ||
≤10 times | 108 (90.0) | 49 (65.3) | |
11-20 times | 9 (7.5) | 16 (21.3) | |
21-30 times | 1 (0.8) | 7 (9.3) | |
>30 times | 0 | 3 (4.0) | |
Missing | 2 (1.7) | - |
Confidence domains “do you feel confident to” | Early in training year (n = 120) | Late in training year (n = 75) | P-value |
---|---|---|---|
Treat patients with VAN? | 3.2±0.98 (3.1-3.4) | 2.3±0.76 (2.1-2.5) | < 0.001 |
Choose an initial VAN dose? | 3.1 ±0.99 (2.9-3.3) | 1.9±0.67 (1.8-2.1) | < 0.001 |
Choose a maintenance VAN dose | 3.1 ±0.88 (3.0-3.3) | 2.0±0.74 (1.9-2.2) | < 0.001 |
Know when the first blood level of VAN should be measured? | 3.2 ±0.90 (3.0-3.3) | 2.1 ±0.70 (2.0-2.3) | < 0.001 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 3.3±0.87 (3.1-3.4) | 2.26±0.73 (2.1-2.4) | < 0.001 |
Know the target therapeutic range for VAN? | 3.1 ±1.1 (2.9-3.3) | 2.1 ±0.81 (1.9-2.3) | < 0.001 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 3.2±0.94 (3.0-3.3) | 2.2±0.91 (2.0-2.4) | < 0.001 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.8±0.98 (3.6-4.0) | 3.2±1.1 (2.9-3.4) | < 0.001 |
Confidence domains “do you feel confident to” | Did not attend prior educational session (n = 25) | Attended prior educational session (n = 49) | P-value |
---|---|---|---|
Treat patients with VAN? | 2.5±0.9 (2.1-2.9) | 2.2±0.7 (2.0-2.4) | 0.09 |
Choose an initial VAN dose? | 2.0±0.6 (1.7-2.3) | 1.9±0.7 (1.7-2.1) | 0.47 |
Choose a maintenance VAN dose | 2.2±0.9 (1.8-2.6) | 1.9±0.7 (1.7-2.1) | 0.15 |
Know when the first blood level of VAN should be measured? | 1.9±0.6 (1.8-2.1) | 2.4±0.8 (2.1-2.8) | <0.05 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 2.5±0.9 (2.2-2.9) | 2.1±0.6 (2.0-2.3) | 0.02 |
Know the target therapeutic range for VAN? | 2.0±0.7 (1.8-2.2) | 2.3±0.9 (1.9-2.7) | 0.13 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 2.5±1.1 (2.1-2.9) | 2.1±0.8 (1.8-2.3) | 0.05 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.4±1.3 (2.8-3.9) | 3.1±1.0 (2.8-3.4) | 0.28 |
Confidence domains regarding vancomycin “do you feel confident to” | JMO without pocket guidelines (n = 17) | JMO with pocket guidelines (n = 58) | P-value |
---|---|---|---|
Treat patients with VAN? | 2.9±0.9 (2.4-3.3) | 2.1±0.6 (1.9-2.2) | < 0.001 |
Choose an initial VAN dose? | 2.3±0.7 (1.9-2.6) | 1.8±0.6 (1.6-2.0) | 0.01 |
Choose a maintenance VAN dose | 2.6±0.8 (2.2-2.9) | 1.9±0.7 (1.7-2.1) | < 0.001 |
Know when the first blood level of VAN should be measured? | 2.4±0.8 (2.0-2.8) | 2.0±0.6 (1.9-2.2) | 0.06 |
Know how often blood levels of VAN should be taken once the patient has reached therapeutic range? | 2.6±0.7 (2.1-3.0) | 2.2±0.7 (2.0-2.3) | 0.03 |
Know the target therapeutic range for VAN? | 2.3±0.8 (2.0-2.7) | 2.0±0.8 (1.8-2.2) | 0.13 |
Interpret high or low VAN levels to use that information to amend the dose or interval? | 2.7±1.1 (2.1-3.3) | 2.1±0.8 (1.8-2.3) | 0.01 |
Manage an infusion-related reaction to VAN (red man syndrome)? | 3.0±1.1 (2.7-3.2) | 3.8±1.2 (3.2-4.4) | < 0.01 |
Medical officer characteristic | No. of all respondents (%) |
---|---|
Sex (female) | 46 (54.1) |
Hospital position | |
PGY1 | 53 (62.4) |
PGY2 | 14(16.5) |
PGY3 | 10(11.8) |
Other | 8 (9.4) |
Hospital | |
Flinders Medical Centre | 66 (77.6) |
Repatriation General Hospital | 13(15.3) |
Noarlunga Health Service | 6(7.1) |
How many times prescribed VAN | |
≤ 10 times | 57 (67.1) |
11-20 times | 16(18.8) |
21-30 times | 5(5.9) |
> 30 times | 5(5.9) |
Missing | 2 (2.3) |
Attended an educational session on vancomycin earlier in the year | 45 (52.9) |
Possess pocket vancomycin guidelines | 58 (68.2) |
Knowledge questions on VAN from clinical vignettes | All | Prescribed VAN ≤10 times (n = 57) | Prescribed VAN >10 times (n = 26) | P-value |
Did not attend prior educational session (n = 40) | Attended prior educational session (n = 45) | P-value |
No pocket guidelines (n = 27) | Possession of pocket guidelines (n = 58) | P-value |
---|---|---|---|---|---|---|---|---|---|---|
What loading dose would you prescribe? | 75 (88.2) | 55 (93) | 20(77) | 0.06 | 37 (92.5) | 38 (84.4) | 32 | 22 (81.5) | 53(91.4) | 0.28 |
What subsequent maintenance dose would you prescribe? | 77 (89.4) | 51 (86) | 25 (96) | 0.26 | 38 (95.0) | 38 (84.4) | 0.16 | 24 (88.9) | 52 (89.7) | 1.00 |
Before which dose should you take the first VAN level? | 81 (953) | 55 (93) | 26(100) | 31 | 39 (97.5) | 42 (93.3) | 0.62 | 26 (96.3) | 55 (94.8) | 1.00 |
If the patient had a creatinine clearance of 30 mlVmin, before which dose would you take the first VAN level? | 77 (89.4) | 51 (86) | 23 (88) | 1 | 32 (80.0) | 42 (93.3) | 0.1 | 21 (77.8) | 53 (91.4) | 0.10 |
What is the therapeutic range (intermittent infusion) for vancomycin recommended by the pathology laboratory? | 81 (953) | 55 (93) | 26(100) | 31 | 38 (95.0) | 43 (95.6) | 1 | 26 (963) | 55 (94.8) | 1.00 |
A patient's initial VAN levels returns as 23.2 mg/L; what dosing regimen will you prescribe? | 70 (82.4) | 47 (80.0) | 23 (88.5) | 0.54 | 36 (90.0) | 34 (75.6) | 0.1 | 20 (74.0) | 50 (86.2) | 0.15 |
When should the patient's next VAN trough level be checked? | 77 (89.4) | 53 (89.8) | 24 (92.3) | 1 | 37 (92.5) | 40 (88.9) | 0.72 | 24 (88.9) | 53(91.4) | 0.71 |
How often should a VAN level be measured once the patient is in the target range (provided stable renal function)? | 79 (92.9) | 54(91.5) | 25(96.1) | 0.66 | 38 (95.0) | 41 (91.1) | 0.68 | 26 (96.3) | 53 (91.4) | 0.66 |
If a patient develops red man syndrome, what changes will you make to the VAN infusion rate? | 51 (60) | 36 (61.0) | 14(53.8) | 0.63 | 25 (62.5) | 25 (55.6) | 0.66 | 14(51.9) | 36 (62.1) | 0.48 |
How many consecutive VAN levels within the target range will the patient require prior to discharge home for outpatient antimicrobial therapy with VAN? | 65 (76.5) | 46 (78.0) | 18(69.2) | 0.42 | 30 (75.0) | 34 (75.6) | 1 | 20 (74.0) | 44 (75.9) | 1.00 |
Values are presented as number (%). PGY, postgraduate year. Early in the training year versus late in the training year, using the Fisher exact test.
Values are presented as mean ± standard deviation (95% confidence interval). Likert score 1 = strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree. VAN, vancomycin. Early in the training year versus late in in the training year, using the unpaired t-test.
Values are presented as mean ± standard deviation (95% confidence interval). Likert score: 1 = strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree. VAN, vancomycin. Attendance versus non-attendance, using the unpaired t-test.
Values are presented as mean ± standard deviation (95% confidence interval). Likert score 1 = strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree. VAN, vancomycin. Using the unpaired t-test.
VAN, vancomycin; PGY, postgraduate year.
Values are presented as number (%). Likert score: 1 = strongly agree, 2 = agree, 3 = not sure, 4 = disagree, 5 = strongly disagree. VAN, vancomycin. Using the 2-sided Fisher exact test.